| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $17.2B | $14.3B | $8.5B | $11.3B | $21.6B | $9.5B | $8.5B | $10.5B |
| EPS (Basic) | $51.95 | $41.07 | $23.05 | $30.42 | $60.25 | $24.94 | $21.18 | $25.53 |
| EPS (Diluted) | $51.32 | $40.54 | $22.87 | $30.06 | $59.45 | $24.74 | $21.03 | $25.27 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1809.3B | $1676.0B | $1641.6B | $1441.8B | $1464.0B | $1163.0B | $993.0B | $931.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $164.3B | $182.1B | $241.6B | $241.8B | $261.0B | $155.8B | $133.5B | $130.5B |
| Total Liabilities | $1684.3B | $1554.0B | $1524.7B | $1324.6B | $1354.1B | $1067.1B | $902.7B | $841.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $125.0B | $122.0B | $116.9B | $117.2B | $109.9B | $95.9B | $90.3B | $90.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-45.2B | $-13.2B | $-12.6B | $8.7B | $0.9B | $-13.7B | $23.9B | $20.4B |
| Investing Cash Flow | $-44.2B | $-49.6B | $-17.3B | $-76.0B | $-30.5B | $-34.4B | $-24.2B | $-22.7B |
| Capital Expenditures | $2.1B | $2.1B | $2.3B | $3.7B | $4.7B | $6.3B | $8.4B | $8.0B |
| Financing Cash Flow | $66.1B | $7.3B | $27.8B | $59.6B | $134.7B | $70.4B | $3.4B | $22.8B |